AnalystsSean Lee
Sean Lee's Stock Forecasts

Analyst Ranking
Top 31%
#1633 out of 5327 analysts
Average Return
+1.99%
Win Rate
30%35 out of 117
Risk vs Reward
Poor
Good

Sean Lee's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Monopar TherapeuticsMNPR
+1,072.87%$3.36$39.42
2024-05-10 -
2025-05-09
Buy
Monopar TherapeuticsMNPR
+398.68%$16.66$83.08
2024-11-11 -
2025-11-10
Buy
Alphatec Holdings IncATEC
+346.70%$3.94$17.60
2020-04-09 -
2021-04-09
Buy
Corvus Pharmaceuticals IncCRVS
+324.48%$3.35$14.22
2025-03-26 -
2026-03-25
Buy
Verastem IncVSTM
+231.90%$2.32$7.70
2024-08-12 -
2025-08-11
Buy

Sean Lee's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dogwood Therapeutics IncDWTX
9Buy$12.00+769.57%Reiterates
2 months ago
Senseonics Holdings IncSENS
4Buy$14.00+173.97%Maintains
2 months ago
Alphatec Holdings IncATEC
14Buy$24.00+190.21%Reiterates
2 months ago
Akari Therapeutics PLCAKTX
3Buy$27.00+153.28%Maintains
4 months ago
Novavax IncNVAX
3Buy$16.00+103.05%Maintains
5 months ago
Kazia Therapeutics LtdKZIA
7Buy$18.00+32.84%Reiterates
6 months ago
Plus Therapeutics IncPSTV
14Buy$25.00+552.74%Maintains
6 months ago
Corvus Pharmaceuticals IncCRVS
4Buy$27.00+91.49%Maintains
6 months ago
Cytosorbents CorpCTSO
14Hold$0.75+97.37%Maintains
8 months ago
Casi Pharmaceuticals IncCASI
10Buy$4.00+1,832.37%Reiterates
a year ago
Myomo IncMYO
6Buy$5.00+455.56%Maintains
a year ago
Verastem IncVSTM
14Buy$14.00N/AMaintains
a year ago
Monopar TherapeuticsMNPR
9Buy$40.00N/AReiterates
a year ago
Gritstone Bio IncGRTSQ
12Hold$0.50N/ADowngrades
2 years ago
Thermogenesis Holdings IncTHMO
6Buy$5.00N/AReiterates
3 years ago
Aceragen IncACGN
1HoldN/AN/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.